Bladder Carcinoma Clinical Trials

A listing of Bladder Carcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 254 clinical trials
Ex VIvo DEtermiNed Cancer Therapy (EVIDENT)

EVIDENT's aim is to test if ex vivo drug screening can predict whether patients with solid cancers will respond, or not respond, to standard care treatments. Patients undergoing standard care surgery to excise their tumour, those undergoing a biopsy, or those having a fluid aspirate of a solid tumour with …

cancer chemotherapy
targeted therapy
hormone therapy
cancer
solid tumour
  • 0 views
  • 25 Mar, 2022
  • 1 location
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate Bladder and Kidney.

Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the …

kidney cancer
cancer
  • 27 views
  • 21 Jan, 2021
  • 1 location
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases

Selected patients suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in …

Accepts healthy volunteers
  • 77 views
  • 24 Oct, 2022
  • 1 location
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment (MARIA)

This study recruits patient with solid tumor types for sample collection and monitoring. Participants will provide blood and archival tissue samples in order to create a Personalized Cancer Monitoring (PCM) assay. This assay will be used to detect circulating tumor DNA (ctDNA) levels in the blood over time and hopefully …

solid tumor
primary cancer
blood transfusion
  • 0 views
  • 23 Mar, 2022
  • 1 location
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patients …

metastasis
bone metastases
cancer
Accepts healthy volunteers
platelet count
  • 97 views
  • 11 Jul, 2022
  • 1 location
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA

Urological malignancies such as prostate cancer and renal cell cancer in Korean population have been increased due to the aged population and the westernized lifestyles. With the advancement of sequencing technologies, use of genetic mutation profiles in cancer detection and progression has been increased. However, use of circulating tumor DNA …

kidney cancer
bladder cancer
bladder tumor
cancer
  • 0 views
  • 21 Feb, 2022
  • 1 location
Evaluation for NCI Surgery Branch Clinical Research Protocols

Background The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective This study will allow patients to under …

white blood cell count
cancer
  • 46 views
  • 24 Oct, 2022
  • 1 location
PAN-study: Pan-Cancer Early Detection Study

The PAN-cancer Early Detection study or PAN-study is a prospective cross-sectional observational case-control study evaluating whether Breath Biopsy can differentiate between patients with and without different cancer types by comparing breath biomarkers for a range of cancer types including patients with gastric, oesophageal, and liver cancer. The research may be …

hematuria
bladder cancer
bladder tumor
cancer
Accepts healthy volunteers
  • 15 views
  • 27 Oct, 2022
  • 1 location
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and …

cancer recurrence
endometrial carcinoma
endometrioid carcinoma
endometrioid adenocarcinoma
lung carcinoma
  • 0 views
  • 07 Oct, 2022
  • 1 location
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (DELFI-L101)

The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.

non-melanoma skin cancer
definitive treatment
lung cancer
cancer
skin cancer
  • 0 views
  • 19 Jun, 2022
  • 1 location